Join the Actiq group to help and get support from people like you.
Actiq News (Page 2)
AAP: Opioid Poisonings Increasing Among Young Children
FRIDAY, Sept. 27, 2024 – Opioid poisonings are increasing among children, according to a study presented at the annual meeting of the American Academy of Pediatrics, held from Sept. 27 to Oct. 1 in...
FDA Says Drug Makers Will Stop Producing Fentanyl 'Lollipops'
FRIDAY, Sept. 20, 2024 – Controversial fentanyl lollipops and similar products will no longer be made by drug makers, the U.S. Food and Drug Administration has announced. Known as TIRF medications,...
New Drug Could Boost Lifesaving Powers of Overdose Drug Naloxone
MONDAY, July 8, 2024 – An experimental drug can supercharge the effects of the lifesaving overdose drug naloxone, potentially improving its effectiveness against new and more powerful opioids like...
12.7 Percent of Adults Using Fentanyl or Heroin Report Ever Using Xylazine
MONDAY, July 8, 2024 – A considerable proportion of adults reporting illegally manufactured fentanyl (IMF) or heroin use also use xylazine, according to research published in the July 4 issue of the...
Drug-Linked Infant Deaths Doubled in U.S. in 4 Years
WEDNESDAY, June 5, 2024 – As an epidemic of drug abuse cuts it way through America, none are left unharmed, even the very young. New data finds that the rate of infants dying from drug-related...
Shared Fentanyl Pipe Residue a New Overdose Danger
THURSDAY, May 23, 2024 – San Francisco researchers report that smoking has now replaced injections as the most common way of ingesting illicit fentanyl. That switch has created a potentially deadly...
FDA Medwatch Alert: Teva Initiates Voluntary Nationwide Recall of Specific Lots of Fentanyl Buccal Tablets CII Due to a Labeling Error
April 27, 2023, Parsippany, NJ – Teva Pharmaceuticals USA, has initiated a voluntary nationwide recall of specific lots of various strengths of Fentanyl Buccal Tablets CII to the Consumer Level....
FDA Medwatch Alert: Drug Safety Communication: All Opioid Pain Medicines - FDA Updates Prescribing Information to Provide Additional Guidance for Safe Use
ISSUE: The FDA is requiring several updates to the prescribing information for both immediate-release (IR) and extended release/long acting (ER/LA) opioid pain medicines. This includes stating for a...
FDA Medwatch Alert: FDA Alerts Health Care Professionals of Risks to Patients Exposed to Xylazine in Illicit Drugs
November 8, 2022 -- Health care professionals should be cautious of possible xylazine inclusion in fentanyl, heroin, and other illicit drug overdoses, as naloxone may not be able to reverse its ...
FDA Medwatch Alert: FDA Alerts Health Care Professionals of Risks to Patients Exposed to Xylazine in Illicit Drugs
November 8, 2022 -- Health care professionals should be cautious of possible xylazine inclusion in fentanyl, heroin, and other illicit drug overdoses, as naloxone may not be able to reverse its ...
FDA Medwatch Alert: Alvogen Inc. Issues Voluntary Nationwide Recall of Fentanyl Transdermal System Due to Product Mislabeling
April 19, 2019 – Alvogen, Inc. is voluntarily recalling two lots of Fentanyl Transdermal System 12 mcg/h transdermal patches to the consumer level. A small number of cartons labeled 12 mcg/h...
FDA Medwatch Alert: Implanted Pumps: Safety Communication - Use Caution When Selecting Pain Medicine for Intrathecal Administration
ISSUE: The FDA is aware that patients undergoing treatment or management of pain are commonly given pain medicines in the spinal fluid (intrathecal administration) that are not FDA approved for use...
FDA Medwatch Alert: Injectable Products by SCA Pharmaceuticals: Recall - Potential Contamination
ISSUE: SCA Pharmaceuticals LLC (“SCA Pharmaceuticals”) is voluntarily recalling various lots of injectable products to the hospital level. There is a potential for the products to contain microbial co...
FDA Medwatch Alert: Opioid Pain or Cough Medicines Combined With Benzodiazepines: Drug Safety Communication - FDA Requiring New Boxed Warnings About Serious Risks and Death
ISSUE: FDA review has found that the growing combined use of opioid medicines with benzodiazepines or other drugs that depress the central nervous system (CNS) has resulted in serious side effects,...
FDA Medwatch Alert: Opioid Pain Medicines: Drug Safety Communication - New Safety Warnings Added to Prescription Opioid Medications
ISSUE: FDA is warning about several safety issues with the entire class of opioid pain medicines. See the FDA Drug Safety Communication for a complete listing. These safety risks are potentially h...
Further information
Related condition support groups
Chronic Pain, Breakthrough Pain, Pain